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Summary
CD23, the low-affinity receptor for IgE (Fc3RII), regu-
lates IgE synthesis and also mediates IgE-dependent
antigen transport and processing. CD23 is a unique
Fc receptor belonging to the C-type lectin-like domain
superfamily and binds IgE in an unusual, non-lectin-
like manner, requiring calcium but not carbohydrate.
We have solved the high-resolution crystal structures
of the human CD23 lectin domain in the presence and
absence of Ca2+. The crystal structures differ signifi-
cantly from a previously determined NMR structure
and show that calcium binding occurs at the principal
binding site, but not at an auxiliary site that appears to
be absent in human CD23. Conformational differences
between the apo and Ca2+ bound structures suggest
how IgE-Fc binding can be both calcium-dependent
and carbohydrate-independent.
Introduction
CD23 is a type II transmembrane glycoprotein and
C-type lectin expressed in various hematopoietic cells
such as mature B cells, follicular dendritic cells, acti-
vated macrophages, monocytes, eosinophils, and plate-
lets. Several ligands have been identified for CD23,
including IgE, CD21 (Aubry et al., 1992), the b2-integrins
CD11b/CD18 (CR3) and CD11c/CD18 (CR4) (Lecoanet-
Henchoz et al., 1997), HLA-DR (Karagiannis et al.,
2001), and the av chain of the vitronectin receptor (Her-
mann et al., 1999; Kijimoto-Ochiai, 2002). CD23 binds
to HLA-DR expressed in B cells, potentially enhancing
antigen presentation to T cells and stabilizing subse-
quent HLA-TCR interactions by interacting with CD21
(Karagiannis et al., 2001). Soluble fragments of CD23
containing the lectin domain also exhibit proinflamma-
tory activities in vitro, stimulating cytokine production
through interactions with non-IgE ligands (Armant
et al., 1995; Hermann et al., 1999; Lecoanet-Henchoz
et al., 1997).
CD23 functions as one of two receptors for IgE anti-
bodies. IgE binds to a high-affinity IgE-Fc receptor
(Fc3RI) expressed on mast cells and basophils. The
aggregation of IgE:Fc3RI by antigen stimulates immune
responses important for defense against bacterial, viral,
and parasitic infections, but it can also trigger an allergic
response (Nadler et al., 2000). Allergic reactions affect up
to 20% of the population in developed countries (Cook-
son, 1999), and the incidence of allergies and asthma
*Correspondence: tedj@northwestern.eduhas steadily risen over the course of this century, causing
significant levels of morbidity and increasing health-care
costs. IgE binding to CD23 (Sutton and Gould, 1993) pro-
vides feedback regulation of serum IgE levels (Lewis
et al., 2004; Payet-Jamroz et al., 2001; Yu et al., 1994)
and can deliver IgE bound antigens for antigen process-
ing or the transport of complexes across epithelial layers
(Montagnac et al., 2005). Two isoforms of human CD23 (a
and b) are generated through the use of different pro-
moters and by differential splicing of exon 2 (Kijimoto-
Ochiai, 2002; Yokota et al., 1992). The resulting proteins
differ in 6–7 residues in the short N-terminal cytoplasmic
domain, and their activities and expression are cell-type
specific (Ewart et al., 2002; Montagnac et al., 2005;
Yokota et al., 1992).
While Fc3RI belongs to a family of immunoglobulin-like
Fc receptors with specificity for distinct antibody classes
(Nadler et al., 2000), CD23 is unique in that it belongs to
the C-type lectin-like domain (CTLD) family of protein
folds. No other antibody class has a receptor homolo-
gous to CD23. CD23 is a type II transmembrane glyco-
protein and a C-type lectin. The N-terminal cytoplasmic
domain is followed by the transmembrane region and
then by a stalk region predicted to form an a-helical
coiled coil (Beavil et al., 1992; Chen et al., 2002; Dierks
et al., 1993). The C-type lectin domain sits atop the stalk.
Beyond the lectin domain there is a stretch ofw30 resi-
dues whose function is not known (Figure 1).
The CTLD family is characterized by the canonical C-
type lectin fold first described for the mannose binding
protein (MBP) structure (Weis, 1997; Weis et al., 1991,
1998). Some CTLD-containing proteins do not bind cal-
cium or carbohydrate but interact with other ligands,
usually proteins (Kijimoto-Ochiai, 2002; Weis, 1997;
Weis et al., 1998). Ca2+ and carbohydrate binding activ-
ities are limited to those CTLDs that contain appropriate
residues at the principal calcium binding site (formed
primarily from loop residues). Variations in the lengths
and sequences of the loops determine the presence or
absence of calcium binding sites.
C-type lectins bind carbohydrate in a calcium-depen-
dent manner by direct ligation of two of the saccharide
hydroxyls to the lectin bound calcium ion. The specific-
ity of the carbohydrate recognition domain (CRD) for
various sugars is determined by interactions of the car-
bohydrate with calcium-ligating residues and with resi-
dues surrounding the calcium binding site. Although
the affinity for monosaccharides is typically weak
(50 mM–10 mM), the overall strength of the interaction
can be increased by two strategies. The binding affinity
can be increased by engaging multiple glycan residues
across an extended carbohydrate binding site (Feinberg
et al., 2001; Somers et al., 2000), and lectin domain oligo-
merization can increase the avidity of the interaction
with carbohydrate arrays.
CD23 binds to some of its ligands in a lectin-like man-
ner by binding to their carbohydrates in a calcium-de-
pendent fashion. CD23 binds to IgE in a non-lectin-like
manner, however, as it can bind to deglycosylated IgE
(Vercelli et al., 1989), indicating that IgE binding is
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(A) Schematic of the domain organization of CD23. The short N-terminal cytoplasmic region (isoforms a and b) is shown in blue, the transmem-
brane region is shown in orange, the stalk and neck regions are shown in green, the CTL domain is shown in yellow, and the 30 C-terminal residues
are shown in purple. The single N-linked glycosylation site (N63) is represented by a circle. The construct described in the text is indicated by the
upper bracket.
(B) Sequence and secondary structure diagram of the apo CD23 CTLD. b strands are indicated by arrows, a helices are indicated by ribbons, and
reverse turns are indicated by purple brackets. Disulfide bonds are shown with green lines. Where the secondary structure of the Ca2+ bound form
differs from that of the apo form, the difference is noted below the diagram. ‘‘l’’ indicates nonregular secondary structure, and ‘‘m’’ means that
these residues are not observed in the Ca2+ bound structure. There are two nonsilent mutations in the construct: H213R and G256S.mediated by protein-protein contacts. While CD23 binds
to IgE in a carbohydrate-independent manner, the bind-
ing is still calcium dependent (Richards and Katz, 1990).
In addition, the binding site on the IgE-Fc for CD23 is
thought to be different from the site for Fc3RI (Garman
et al., 2000; Wurzburg and Jardetzky, 2002) and may in-
volve a unique conformational state of the IgE-Fc (Wurz-
burg et al., 2000; Wurzburg and Jardetzky, 2002).
The CD23 binding site on IgE has been mapped to the
outer face of the C33 domain (Chretien et al., 1988; Gha-
deri and Stanworth, 1993; Sayers et al., 2004; Vercelli
et al., 1989), and the oligomeric state of CD23 signifi-
cantly affects IgE binding affinity. Each IgE-Fc dimer
contains two potential CD23 binding sites, and it has
been demonstrated that two CD23 lectin domains bind
to one IgE-Fc (Shi et al., 1997). The native CD23 structure
is thought to be trimeric, with a binding affinity of
w1028M (Chen et al., 2002; Dierks et al., 1993; Kelly
et al., 1998). Oligomeric CD23 binds IgE with a dual affin-
ity, with the lower-affinity component attributed to the
binding of a single lectin domain, and the higher-affinity
component attributed to the binding of a second lectin
domain (Chen et al., 2002). Monomeric CD23 lectin do-
mains bind to the IgE-Fc with substantially lower affinity
(Kd =w10
25M) than oligomeric CD23 (Chen et al., 2002;
Shi et al., 1997).
Oligomerization of the CD23 lectin domain is not suf-
ficient for high-affinity binding, however, as substitution
of the CD23 stalk with stalk regions from other proteins
results in the loss of high-affinity binding (Chen et al.,
2002; Kelly et al., 1998). When the entire ectodomain of
CD23 is fused to a heterologous trimerization domain,
high-affinity binding is observed (Chen et al., 2002; Kelly
et al., 1998); deletion analysis of the native stalk has im-
plicated a region near the lectin domain (the ‘‘neck’’) asnecessary for this high-affinity interaction (Chen et al.,
2002). While the stalk region enhances CD23 oligomeri-
zation, the neck region appears to be less tightly associ-
ated, potentially allowing for some flexibility in orienting
the lectin domains to bind to IgE, enabling the high-affin-
ity interaction (Kilmon et al., 2004). While CD23 oligo-
merizes on cell surfaces (Kilmon et al., 2004), the protein
is naturally susceptible to endogenous proteases, and
cleavage from the membrane and additional proteolysis
release soluble fragments (37 kDa, 33 kDa, 29 kDa, 25
kDa, and 16 kDa) that contain the lectin domain and
have been reported to have various cytokine activities
(Armant et al., 1995; Hermann et al., 1999; Lecoanet-
Henchoz et al., 1997).
We have solved the crystal structures of the soluble
C-terminal fragment of CD23 in the presence and ab-
sence of Ca2+. Calcium binding is observed at the prin-
cipal binding site, but not at an auxiliary site, in contrast
to the conclusions of a recent NMR study of CD23 (Hib-
bert et al., 2005). In the crystal structure of the apo form,
the principal calcium binding site is occupied by an argi-
nine from a neighboring loop, while in the calcium bound
form, this arginine and the surrounding loop residues are
disordered. Differences in the CD23 structure associ-
ated with calcium binding overlap with regions previ-
ously identified as important for IgE-Fc interactions
(Bettler et al., 1992), suggesting that localized changes
surrounding the principal calcium binding site affect
the affinity for IgE.
Results and Discussion
A fragment of human CD23 (sCD23), including residues
150–321 (Figure 1), was expressed in insect cells by us-
ing the baculovirus system and was purified to
CD23 Crystal Structure
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Space Group (Crystal) P212121 (Ca
2+) C2 (apo, cryo) C2 (apo, RT)
Unit cell dimensions
a (A˚) 40.31 112.4 113.2
b (A˚) 51.26 50.7 51.6
c (A˚) 58.77 75.1 75.8
b (º) 127.1 126.7
Molecules/asymmetric unit 1 2 2
Resolutiona (A˚) 30–1.3 (1.32–1.30) 30–1.5 (1.66–1.50) 30–2.75 (2.85–2.75)
Completenessa 99.4% (100%) 99.5% (99.8%) 99.6% (100%)
Reflections, unique (total) 30,523 (214,231) 53,947 (353,285) 9,254 (34,320)
Average redundancy >7 7 3.7
<I/sI> 41.6 18.7 9.6
Rsym
b (%)a 9.0 (33.8) 5.1 (28.1) 14.4 (45.2)
Number of reflections (free) 28,870 (1,561) 53,947 (2,727) 9,254 (480)
Rcryst/Rfree
c (%) 16.9/20.2 12.9/17.0 25.7/28.1
Atoms, total 1,173 2,535 2,169
Protein 999 2,169 2,090
Water 173 366 79
Calcium ion 1 0 0
Average B factor (A˚2)
Protein 17.7 22.9 31.2
Water 32.5 39.4 35.0
Calcium ion/water ligands 15.7/25.6 — —
Rms deviations from ideality
Bond angles 1.497º 1.376º 1.093º
Bond lengths 0.020 A˚ 0.022 A˚ 0.004 A˚
Ramachandran plot
Most favored regions (%) 91.4 89.7 81.6
Allowed regions (%) 5.7 9.1 17.5
Generous regions (%) 2.9 1.3 0.9
Disallowed (%) 0.0 0.0 0.0
a Values for the highest-resolution shell are shown in parentheses.
b Rsym = ShSi(jIi(h)j 2 j<I(h)>j)/ShSiIi(h), where Ii(h) = the observed intensity and <I(h)> = the mean intensity for multiple measurements.
c Rcryst and Rfree = ShkF(h)oj 2 jF(h)ck/ShjF(h)oj for the working and test set reflections, respectively.homogeneity. sCD23 was crystallized in the presence
and absence of Ca2+. Apo sCD23 crystals diffracted X-
rays to a resolution of 1.5 A˚, while the Ca2+-containing
sCD23 crystals diffracted X-rays to 1.3 A˚ resolution (Ta-
ble 1). The apo crystals grew in space groupC2 and con-
tained two monomers per asymmetric unit, while the
Ca2+ bound crystals grew in space group P212121 and
contained a single monomer per asymmetric unit. The
structure of apo sCD23 was solved by molecular re-
placement by using a model based on the asialoglyco-
protein receptor. The model was refined and subse-
quently used to solve the crystal structure of the Ca2+
bound sCD23. Models were refined to an overall Rfactor
(Rfree) of 12.9% (17%) for the apo sCD23 and 16.9%
(20.2%) for the Ca2+ bound sCD23 (Table 1).
Description of the Apo CD23 Structure
The secondary structure and disulfide map of the CD23
lectin domain are shown in Figure 1. The core is very
similar to other CTLs and has Ca rms deviations ranging
from 0.97 to 1.53 A˚ (over 106–118 Ca pairs) when com-
pared to the asialoglycoprotein receptor, mannose bind-
ing protein, and DC-SIGN. In addition to the five major
b strands, two a helices, and two disulfides common to
CTLs, the CD23 lectin domain contains two additional
b strands at the N terminus (b21 and b0), two short
b strand regions within the domain (b1–2 and b2–3), two
additional disulfides, and eight tight turns (Figure 2A).
The model for apo sCD23 starts at residue F158 (Figures
1 and 2) and proceeds into a short b strand (b21). The firstcysteine of the domain (residue 160) forms a disulfide
with C288, linking the beginning and end of the lectin do-
main. This additional disulfide is not conserved but is
present in some family members such as DC-SIGN. A
second cysteine (C163) forms a disulfide between C163
and C174, classifying CD23 as a member of the long-
form CTLDs. Both a helices in CD23 end with short
stretches of 310 helix and are more similar in length to
the helices in MBP than to those of the more closely re-
lated DC-SIGN. Reverse turn 4 changes conformation
in the Ca2+ bound CD23 (Figure 2B), and residues 226–
231 (including turn 4) will be referred to as Loop 1. The
last b strand of the domain (b5) is unusually long and
twisted and continues almost to the end of the structure.
Electron density for the 30 C-terminal residues (292–321)
of the construct is not observed, and these residues are
not part of the predicted lectin domain.
Structural Changes in the Ca2+ Bound CD23
The core of the lectin domain of the Ca2+ bound CD23 re-
mains almost unchanged compared to that of the apo
CD23: the average rms deviation over 118 Ca atom pairs
is only 0.30 A˚ (0.29 A˚ over all atoms, 904 pairs). However,
the structure of the Ca2+ bound CD23 lectin domain dif-
fers significantly in three regions: the calcium binding
site, the Loops 1 and 4 region, and the N and C termini
(Figure 2B). Residues that act as calcium ion ligands be-
come reordered upon calcium binding, and most of the
changes are in the side chain orientations (Figure 3).
One residue that sometimes changes in Ca2+ versus
Structure
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(A) A ribbon diagram of the apo CD23 CTLD
shown colored from blue (N terminus) to red
(C terminus). The canonical b strands are la-
beled 1–5 and are shown as arrows, the a he-
lices are shown as ribbons, and Loops 1, 3,
and 4 are indicated. Disulfide bonds are
shown in magenta. The observed N and C ter-
mini of the Ca2+ bound CD23 are slightly
shorter, and residues 253–257 are missing.
(B) A ribbon diagram overlay of the apo and
Ca2+ bound CD23 structures at the Loops 1
and 4 regions. The view is rotated w90º
from the orientation in (A). The apo form is
shown in blue, and the Ca2+ bound form is
shown in red; bound calcium and water li-
gands are shown as spheres. Loop 4 is miss-
ing from the Ca2+ bound form, while the con-
formation of Loop 1 changes significantly.apo forms of CTLs is the conserved binding site proline
(P250 in CD23). In Ca2+ bound MBP structures, this pro-
line is always observed in the cis conformation, but in
apo structures it has been observed in both the cis and
trans conformations (Ng et al., 1998). In CD23, P250 is
observed in the cis conformation in both the Ca2+ bound
(one chain) and apo forms (two chains).
Upon calcium binding, the conformation and flexibility
of Loops 1 and 4 change significantly (Figure 2B). Loop 4
is adjacent to the Ca2+ binding site on one side and packs
next to Loop 1 on the other side. In the apo form, Loop 4
(residues 253–257) is ordered, and the side chain of R253
points into the Ca2+ binding site. When calcium binds, it
replaces the R253 side chain in the binding site, and
Loop 4 residues 253–257 become disordered (Figure
2B). Loop 1 residues (including turn 4) are affected by
the increased flexibility of Loop 4. The main chain path
changes, moving Loop 1 toward Loop 4 and converting
reverse turn 4 from a type I to a type III0 turn. The change
in conformation at this turn is most evident in the move-
ment of residue L228, which points away from Loop 4 in
the apo form but points toward Loop 4 and moves 5.4 A˚
closer to it in the Ca2+ bound form. Except for the N and C
termini, modeled residues in these loops have higher
temperature factors than the rest of the structure, withaverage B factors of 41 A˚2 and 30 A˚2, respectively, com-
pared to an overall B factor of 18–23 A˚2 (in the two forms).
The observed N and C termini of the protein are trun-
cated in the Ca2+ bound form, with residues 158–159
and 289–291 missing from the Ca2+ bound structure.
The effect on the secondary structure is the loss of
the b21 strand and the shortening of the b5 strand (Fig-
ure 1). These changes are distant from the calcium bind-
ing site.
The Calcium Binding Site
The crystal structure of the lectin domain of MBP-A re-
vealed three calcium ion binding sites (Weis et al.,
1992): the principal site (site 2) conserved among CTLs
where carbohydrate binding occurs, an auxiliary site
(site 1) found in many but not all CTLs, and a third site
(site 3) that was most likely due to the crystallization con-
ditions. Unlike MBP and DC-SIGN, human CD23 con-
tains only the principal Ca2+ binding site. The auxiliary
calcium site in MBP is formed by carboxylate-containing
residues from Loops 1 and 4—D189, E193, D216, and
D222. Proteins lacking the auxiliary calcium binding
site have shortened loop regions and/or lack appropriate
residues for calcium ligation. Of the four carboxylate li-
gands in MBP, only one is conserved in CD23 (N225,Figure 3. CD23 Principal and Auxiliary Calcium Site Ligands in Various Species
An alignment of CD23 sequences from rat, house mouse, horse, cow (partial), and human sources showing the calcium-ligating residues. For com-
parison, the corresponding residues from the human asialoglycoprotein receptor (HL), rat MBP-A, and human DC-SIGN are shown above the
CD23 sequences. Principal site ligands are highlighted in pink, the conserved cis proline is highlighted in blue, and auxiliary site ligands are high-
lighted in green. Nonconservative substitutions in the human sequence are highlighted in yellow. The glutamate marked with an asterisk acts as
both a principal (side chain O3) and auxiliary (main chain O) site ligand. The human CD23 numbering is given below the sequences.
CD23 Crystal Structure
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(A) The Ca2+ bound CTLD. The calcium is
shown as a green sphere, and its ligands
come from residues E249 (O31), T251 (Od1),
N (Od1), and D270 (Od2 and O) and two water
molecules (red spheres). Ligand bonds are
indicated with dashes, and the beginning of
the missing Loop 4 residues (253–257) is indi-
cated with an arrow. E249, P250, and T251
form the ‘‘EPT’’ motif discussed in the text.
(B) The Ca2+ binding site in the apo form, with
the guanidinium group of R253 occupying the
former calcium ion position. Ionic and hydro-
gen bonds formed by the guanidinium group
are indicated with red dashes. Residues that
form new contacts with the calcium-ligating
residues are also shown; hydrogen bonds
are indicated by blue dashes.K229, S252,D258) (Figure 3). Although N225 Od1 and the
S252 Og might serve as calcium ligands, the orientation
of the potential ligands is not appropriate.
The principal site calcium ion in MBP usually has eight
coordinating ligands; six ligand atoms are contributed by
the protein and the remaining ligands are contributed ei-
ther by two water molecules or by two vicinal hydroxyls
from bound carbohydrate (Ng et al., 1998; Weis et al.,
1992). The six protein ligands are oxygen atoms, either
side chain or main chain, from residues such as Asp,
Asn, Glu, and Gln. A 3 residue sequence motif, contain-
ing the conserved cis proline (P250 in CD23), determines
the sugar binding specificity. The ‘‘EPN’’ motif is found in
lectins that preferentially bind mannose-type sugars
(vicinal 3- and 4-hydroxyls are equatorial), while the
‘‘QPD’’ motif is found in lectins that preferentially bind
galactose-type sugars (3-hydroxyl is equatorial, while
the 4-hydroxyl is axial). The calcium-ligating residues
bind not only to the calcium ion, but they also make
key contacts to the carbohydrate. The intimate contacts
linking the calcium ion to its protein ligands and the same
protein residues to the carbohydrate are essential for the
stability of the ternary complex. For example, when the
MBP-A site was mutated from EPN to EPD, the oxygen
ligand to the calcium ion was preserved, but the hydro-
gen bond donor for the sugar-OH group was lost. This
mutant MBP-A bound calcium but was unable to bind
carbohydrate (Weis et al., 1992).
In CD23, the calcium ion is heptavalently coordinated
to atoms from four protein residues, E249 (O31), T251
(Og1), N269 (Od1), and D270 (Od2) and (O), and two wa-
ter molecules (Figures 4 and 5). The resulting geometry
of the calcium coordination is square planar bipyramidal
instead of a pentagonal bipyramidal. Three features of
this site are unusual. First, the motif at the preference-
determining residues is ‘‘EPT’’ (residues 249–251), not
‘‘EPN’’ or ‘‘QPD.’’ The threonine hydroxyl group may
be able to contribute both an oxygen lone pair to the cal-
cium and form a hydrogen bond to a carbohydrate hy-
droxyl, maintaining both calcium and sugar binding ca-
pabilities, but the geometry of the interactions will not be
the same as that with an Asn residue. The tunicate lectin
TC14 has a serine at this position that fails to act as a cal-
cium ligand but binds carbohydrate through a water
molecule (Poget et al., 1999). The Thr side chain, while
bulkier than that of Ser, is shorter than an Asn or Aspside chain, and therefore a sugar moiety might have to
move deeper into the site to bind to the Thr.
The second unusual feature of the CD23 Ca2+ binding
site is that Loop 4 is disordered (residues 253–257 are
not observed). While disorder has been observed at
a binding site loop in an apo CTLD structure (Ng et al.,
1998), disorder in a calcium bound form is unusual and
suggests that Loop 4 could adopt distinct conforma-
tions in different CD23 complexes with either IgE and/
or carbohydrate.
The third unusual feature of this site is that residue
E257 (MBP-A E193 equivalent) was expected to contrib-
ute a calcium ligand; however, electron density was not
observed for this residue. It is the last of the Loop 4 res-
idues (R-S-Q-S-E) missing from the structure. In human
P-selectin, the equivalent residue (E88) is swung out of
the site in the Ca2+ bound form and cannot contribute
a ligand for the calcium (Graves et al., 1994; Somers
et al., 2000); however, binding site alterations are ob-
served upon carbohydrate binding. In E-selectin, the
side chain of N83 rotates so that it can act as a calcium
ligand and bind to the sugar moiety through a water mol-
ecule. In P-selectin, a more dramatic change is ob-
served upon binding a glycopeptide. E88 moves into
the site to coordinate the calcium ion and to bind the
carbohydrate directly (Somers et al., 2000). The return
to the binding site is accomplished by a large movement
of the loop containing E88, which is unusual in that the
carbohydrate binding site is usually ‘‘preformed’’ in the
presence of calcium and significant changes upon car-
bohydrate binding are not expected. It is possible that
carbohydrate binding to CD23 will induce a change in
Loop 4, bringing E257 into the calcium coordination
sphere. The change would be quite dramatic, however,
as the carboxylate oxygens of E257 are w16 A˚ away
from the calcium binding site in the apo form. A neigh-
boring residue, D258, might be the preferred ligand as
its carboxylate oxygens are only w6 A˚ away from the
calcium site in both the apo and Ca2+ bound forms,
and a smaller change in Loop 4 would be needed to
bring this residue closer to the calcium ion.
Apo CD23
Typically, apo CTLs are less ‘‘rigid’’ than their Ca2+ bound
forms—Loop 4 (adjacent to the Ca2+ binding site) has
been observed in multiple conformations in MBP (Ng
Structure
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Site and the Role of Arg-253
(A) The calcium ion is heptavalently coordi-
nated in CD23 (distances in A˚). Four CD23
residues (E249, T251, N269, and D270) con-
tribute five ligands (boxed in blue) for the cal-
cium ion. Two water molecules occupy the
remaining ligand positions. In the absence
of Ca2+, the residues in the binding site rear-
range, and the former calcium ligands form
alternate interactions with other CD23 atoms
(shown in green).
(B) The role of R253. In addition to the rear-
rangement of the calcium binding residues
in the apo form, R253 moves into the Ca2+
binding site, and its guanidinium group oc-
cupies the former calcium ion position.
Atoms from R253 interact directly with 3 of
the 4 residues that normally act as Ca2+ li-
gands, and former calcium ligating residues
form new interactions.et al., 1998), and apo CTLs are susceptible to protease
cleavage. Unusually, apo CD23 is more structured in
the crystals than in the Ca2+ bound form, with all residues
of Loop 4 well ordered and in essentially the same con-
formation in both apo protomers. Unlike other apo
CTLs, the ‘‘empty’’ calcium binding site of CD23 is actu-
ally filled by the side chain of a Loop 4 residue, Arg-253,
that has its Nh1 atom occupying the calcium ion position
(Figure 4B). Arg-253 makes six contacts within the site
(Figures 4B and 5), including contacts with three of the
four calcium binding residues. In addition, every atom
that acts as a ligand to the calcium ion forms a new inter-
action in the apo structure. The extensive contacts that
Arg-253 makes in the apo form probably help to stabilize
Loop 4 in its observed conformation. Since Loop 4 would
be expected to be more mobile and exposed in the Ca2+
bound form of CD23, protease digestion experiments
with apo and Ca2+ bound CD23 were carried out with
trypsin, Glu-C, and subtilisin (data not shown). No evi-
dence for enhanced proteolytic cleavage of the Ca2+
bound CD23 was obtained. However, the disordered
region in Loop 4 is sufficiently short (5 residues) that it
may not be accessible to proteases.
Comparison of the NMR and Crystal Structures
of the CD23 Lectin Domain
The structure of derCD23 (residues 156–298) was re-
cently determined by NMR (Hibbert et al., 2005). The re-
gion surrounding the principal calcium binding site (res-
idues 245–258) is poorly defined in the NMR structures
(Figure 6A). In contrast, the crystal structures are well
defined in this region (except for residues 253–257,
which are not observed in the Ca2+ form) and have es-sentially the same backbone conformation in both the
apo and Ca2+ bound forms. None of the NMR structures
contain a geometrically competent principal calcium
binding site. This may be due, in part, to the modeling
of the conserved Pro-250 of the EPT motif as the trans
instead of the cis isomer observed in all calcium bound
CTLs (Figure 6B). Both the apo and Ca2+-containing
crystal structures have geometrically competent princi-
pal calcium binding sites (occupied in the apo form by
the guanidinium group of R253).
In the NMR experiments, chemical shift changes ob-
served upon calcium binding were also attributed to
the binding of a calcium ion at the putative auxiliary
site rather than at the principal site. In contrast, the crys-
tal structure clearly shows calcium bound at the princi-
pal binding site (14s electron density peak), while no ex-
tra electron density is observed in the region of the
potential auxiliary binding site. A sequence alignment
of CD23 from horse, cow (partial sequence), mouse,
rat, and human sources shows that the principal calcium
binding site is preserved across all species (Figure 3), al-
though it is slightly altered in the human sequence
(N251T). CTLs that have an auxiliary binding site have ei-
ther three or four carboxylate side chain ligands for the
calcium ion. The auxiliary site is conserved in equine,
bovine, murine, and rat CD23 sequences, but not in hu-
man CD23; only one of the carboxylate ligands is pres-
ent. In the crystal structures, the potential auxiliary site
residues are not oriented appropriately to ligate a cal-
cium ion. It is unlikely that the auxiliary calcium binding
site exists in human CD23.
Of the 8 residues experiencing significant 1H chemical
shifts in the presence of calcium in the NMR
CD23 Crystal Structure
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from the NMR and Crystal Structures
(A) An overlay of the main chains from the
NMR structures (1T8C, shown in green) with
the apo (blue) and calcium bound (magenta)
CD23 from the crystal structures. The Ca
atoms of P250 are shown as spheres for
each model.
(B) A comparison of the positions of the con-
served P250. This proline is modeled as the
trans isomer in all of the NMR structures
(model 1 shown), but it is modeled as the
cis isomer in the crystal structures.experiments, 4 were in or near Loop 1 (N225, K229,
G230, and E231), and 3 were in or near the principal cal-
cium binding site (D270, A271, D274). The crystallo-
graphic observation of a large change in the position
of Loop 1 upon calcium binding is consistent with these
NMR data. Residues 252–257 of Loop 4 were not as-
signed in the NMR structures, and therefore changes
in this loop upon calcium binding could not be observed.
The fact that these residues could not be assigned is
also consistent with the observation that these residues
are disordered in the calcium-containing crystal struc-
ture. The assumption that the largest changes in chem-
ical shift identify the location of calcium binding is not
borne out by the crystal structures.
Finally, a single core packing arrangement is ob-
served for both the apo and Ca2+ bound CD23 crystal
structures, and this arrangement differs from the two
core packing arrangements observed in the NMR struc-
tures (database entries 1T8C and 1T8D).
The Carbohydrate Binding Site
Carbohydrates bind at the principal calcium binding site
of CTLs, with the ligand preference determined by the 3
residue motif that includes the conserved cis proline.
Preferential binding to mannose-like sugars is observed
in lectins containing the ‘‘EPN’’ motif, while those lectins
containing the ‘‘QPD’’ motif preferentially bind galac-
tose. Murine CD23 has the ‘‘EPN’’ motif, suggesting
that it preferentially binds mannose-type carbohydrate,
while human CD23 has ‘‘EPT’’ at the binding site. CD23
has been reported to bind to both mannose-type carbo-
hydrates (Pochon et al., 1992; Richards and Katz, 1990)
and galactose-containing carbohydrates (Kijimoto-
Ochiai, 2002; Kijimoto-Ochiai and Uede, 1995; Richards
and Katz, 1990). We modeled N-acetylglucosamine,
mannose, and galactose into the principal calcium bind-
ing site of the Ca2+ bound CD23. Each of the sugars could
be accommodated in the site; however, the hydrophobic
face of galactose makes fewer van der Waals contacts in
the CD23 site than it does in the TC14 lectin structure be-
cause of the substitution of a key tryptophan residue for
arginine in CD23. There are no steric hindrances in the
current structure that would prevent any of these sugar
moieties from binding. However, because 5 residues of
Loop 4 near the calcium binding site are not observed
in the Ca2+ bound CD23 structure (including expected
Ca2+ ligand E257), we cannot be certain that the site
will not change upon carbohydrate binding.
Larger oligosaccharides can make additional contacts
to the lectin outside the principal calcium binding site, as
illustrated by the structures of DC-SIGN bound to oligo-saccharides (Feinberg et al., 2001; Guo et al., 2004). Ad-
ditional binding sites are likely to be very specific to each
lectin, depending on its sequence and surface topology.
For example, in DC-SIGN, a carbohydrate binding
pocket is created by a ‘‘gap’’ between the end of the a2
helix and an adjacent turn. The position of the a2 helix
is one of the more variable structural elements in the
CTLDs. In CD23, the main chain paths of the helix and
turn close the gap, eliminating this pocket. At another
distal site, 3 residues in DC-SIGN (D367, L371, and
K373) form part of a hydrogen bonding network that ac-
commodates binding of a sugar moiety. In CD23, the
structurally homologous residues L277, A271, and
M361 instead form a hydrophobic interaction. In addition
to forming additional carbohydrate binding sites, surface
residues can be used to discriminate between carbohy-
drate linkages. In DC-SIGN, F313 binds to distal carbo-
hydrate moieties that have high mannose linkages while
excluding complex N-linked glycans. Although F313 is
part of a 2 residue insertion relative to CD23, two
arginine guanidinium groups point toward each other
at approximately the same location in CD23, forming
a ‘‘hump’’ on the protein surface.
Implications for IgE Binding
The IgE binding site was first identified as being confined
to the lectin domain of CD23 (Bettler et al., 1989), and ho-
mology scanning mutagenesis and monoclonal antibody
binding further identified six short segments important
for IgE binding to two regions between residues 165–
190 and 224–256 (Bettler et al., 1992). While mutagenesis
alone could not distinguish between substitutions that
directly affected IgE binding from those that affected
the conformation of the protein, monoclonal antibody
binding results suggested that changes in segments
165–173 and 176–183 affected the global conformation
of the protein. These segments contain the b0 strand
and the two tight turns bracketing it as well as part of
the b1 strand. The b0 strand may form part of the neck re-
gion that is necessary for the correct orientation of the
lectin domains for optimal IgE binding (Kilmon et al.,
2004), while the b1 strand forms hydrogen bonds with
the b0 and the b5 strands. The remaining four segments
were determined to disrupt IgE binding only. Segment
185–190 is from the N-terminal half of the a1 helix. Seg-
ment 224–233 contains Loop 1, whose main chain path
changes dramatically upon calcium binding (Figure
2B). Segment 238–243 contains part of Loop 2, and seg-
ment 251–256 contains one of the calcium-ligating resi-
dues and most of Loop 4, which becomes disordered
upon calcium binding. The four segments define
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domain’s carbohydrate binding face and continuing
around the top ‘‘back side’’ of the domain (Figure 7). In
addition, residues from Loops 1, 2, and 4 surround a hy-
drophobic pocket on the back face of the lectin. The
crystal structure of CD23 shows that residues in segment
224–233 (Loop 1 region) contact adjacent residues from
the other three segments (185–190, 238–243, and 251–
256), suggesting that Loop 1 residues form the core of
the IgE binding surface. Changes in the other segments
might affect the position of Loop 1 residues and thereby
alter IgE binding. Although Loop 1 is removed from the
calcium/carbohydrate binding site, the conformations
of Loops 1 and 4 change upon calcium binding, offering
an explanation for the calcium-dependent, but carbohy-
drate-independent, binding of IgE to CD23.
Calcium may play a purely structural role in IgE binding
by affecting the CD23 conformation, as suggested by the
crystal structures, or, alternatively, it may participate di-
rectly in the protein:protein interaction interface. The
transition of Loop 4 from ordered (apo form) to
disordered (calcium bound form) may be linked to the
apparently contradictory requirement for calcium in a
carbohydrate-independent interaction. If residues re-
quired for IgE-Fc binding are locked in a nonbinding or
disfavored conformation in the apo form, the binding of
calcium (and subsequent disordering of Loop 4) might
liberate these residues to assume an IgE binding-com-
petent conformation. While R253 is not conserved in
other CD23 sequences, these proteins do apparently
contain the auxiliary calcium binding site, which could
also similarly influence Loop 4 and Loop 1 conformations
in a calcium-dependent manner. Given that some CD23
isoforms are involved in transporting IgE complexes
(Ewart et al., 2002; Montagnac et al., 2005; Yokota
et al., 1992), it seems possible that calcium-dependent
IgE binding could also provide a means of regulating
IgE binding and release in a physiological setting.
Experimental Procedures
Protein Expression and Purification
The full-length human CD23 gene was obtained from Invitrogen
(GeneStorm Clone H-M15059M). The clone contained two nonsilent
sequence changes (H213R and G256S). R213 occurs at the end of
the a2 helix and is distant from both the principal and auxiliary cal-
Figure 7. A Surface Representation of the CD23 CTLD
Residues implicated by mutagenesis studies as being important for
IgE binding are shown in blue, residues whose positions change
from the apo to the Ca2+ bound form are shown in red, and the over-
lap of these residues is shown in magenta.cium binding sites and from Loops 1 and 4. S256 occurs in the mid-
dle of Loop 4, but it does not appear to have diminished the flexibility
of this loop significantly since this loop is disordered in the calcium
bound form. A construct containing the lectin domain of the mature
CD23 (residues 150–321) was generated by PCR and subcloned into
the baculovirus transfer/expression vector pBACgus-3 (Novagen).
This construct will be referred to as soluble CD23 or sCD23. Re-
combinant baculovirus was generated with the Baculogold system
(Pharmingen) by using standard methods. Sf9 and Sf+ cells (Protein
Sciences) were used to produce viral stocks.
sCD23 was expressed in Sf+ cells grown in shaker flasks in HyQ
SFX insect medium (HyClone) to 1.5 3 106 cells/ml and infected
with high-titer virus stock. Three days postinfection, supernatants
were harvested, filtered, treated with a protease inhibitor cocktail,
dialyzed against 6 volumes of 50 mM sodium phosphate, 300 mM
sodium chloride (pH 7.0) at 4ºC, and purified with Talon metal affinity
resin (CLONTECH Laboratories, Inc.). Approximately 12 mg protein
were obtained from 2 liters of supernatant. The N-terminal S and
His tags were removed from the fusion protein by enterokinase di-
gestion, which was confirmed by SDS-PAGE and by Western blot-
ting with anti-His (Novagen) and anti-CD23 monoclonal antibodies
(Santa Cruz Biotechnology, Inc.). The resulting sCD23 protein con-
tains three additional vector-derived residues (S-P-G) at the N termi-
nus. sCD23 was further purified by using gel filtration (Superdex 75)
and anion exchange chromatography (Q2). Purified, recombinant
sCD23 has a calculated molecular weight of 19,500, but it migrates
on SDS-PAGE with an apparent molecular weight of 24,000.
Crystal Growth and Treatment
Crystals of sCD23 were initially obtained from a mixture (6.5:1 molar
ratio) of sCD23 and IgE-Fc C33-4 protein (Wurzburg et al., 2000), but
they were subsequently reproduced with sCD23 alone. Crystals
were grown by vapor diffusion by using the hanging drop method.
Protein (10 mg/ml in 10 mM Tris [pH 8.0]) was mixed 1:1 with precip-
itant (1.2 M sodium monobasic phosphate, 0.8 M potassium dibasic
phosphate, 0.1 M Caps buffer [pH 10.5], and 0.2 M lithium sulfate; fi-
nal pH 6.2) and incubated at room temperature. Crystals were har-
vested into 1.3 M sodium phosphate, 0.7 M potassium phosphate,
0.1 M Caps buffer (pH 10.4), and 0.2 M lithium sulfate (final pH 6.2).
Crystals used for cryo-data collection were transferred from harvest
buffer to Paratone oil and flash cooled in liquid nitrogen.
sCD23 was also crystallized with Ca2+ in the presence of IgE-Fc
C33-4 (2:1 molar ratio). Protein (10 mg/ml in 30 mM Tris [pH 8.0],
10 mM CaCl2) was mixed 1:1 with precipitant (17% [w/v] polyethyl-
ene glycol 4000, 100 mM Mes buffer [pH 6.0]) and incubated at
room temperature. A single crystal was harvested into 21% polyeth-
ylene glycol 4000, 100 mM MES [pH 6.0], 5 mM CaCl2, transferred
into Paratone oil, and flash cooled in liquid nitrogen.
Data Collection and Processing
Both apo CD23 crystals belong to space group C2 and have similar
cell dimensions (Table 1). Data were collected from the room tem-
perature crystal to 2.75 A˚ by using a rotating anode source (l =
1.54 A˚) and a Mar 345 Image Plate detector, and processed by using
the HKL suite of programs (Otwinowski and Minor, 1997). Data from
the cryocooled crystal (2160ºC) were collected at the Advanced
Photon Source, DND-CAT 5-ID beamline (l = 0.97895 A˚) to 1.5 A˚ by
using a MarMosaic detector and processed with XDS (Kabsch, 2001).
Data from the Ca2+-containing crystal were collected at 2160ºC
to 1.3 A˚ at the Advanced Photon Source, COM-CAT beamline
(l = 1.02336A˚) by using a MarCCD detector (Table 1). The crystal
belongs to space group P212121 with unit cell dimensions a = 40.31
A˚, b = 51.26 A˚, c = 58.77 A˚. The data were processed and integrated
with the HKL suite (Otwinowski and Minor, 1997).
Structure Determination and Refinement
A model for CD23 was generated from the carbohydrate recognition
domain of the H1 subunit of the asialoglycoprotein receptor (Meier
et al., 2000) (PDB entry 1DV8) by deletion and mutation of residues,
yielding a 121 residue model for the 175 residue sCD23 (with 44 res-
idues identical to those of the CD23). Molecular replacement with
CNS (Brunger et al., 1998) with data from the room temperature crys-
tal gave a solution with two CD23 molecules per asymmetric unit and
a correlation coefficient of 33.1%. An Rfree test set was generated by
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fined with CNS (Brunger et al., 1998) with all data from 30 to 2.75 A˚
resolution and an jFj > 0. An anisotropic bulk solvent correction
was applied. Noncrystallographic symmetry restraints did not im-
prove the Rfree and were not used during refinement. Slight differ-
ences in the main chain (rmsd over 118 Ca pairs of 0.34 A˚) and
side chain positions were apparent. Several cycles of building with
O (Jones et al., 1991) and refinement with CNS (Brunger et al.,
1998) yielded a model with an Rwork of 25.7% and an Rfree of
28.1%. This model contained residues F158–P291 and 79 water
molecules and was missing residues 226–229 in chain A, residues
227–229 in chain B, and 11 residues from the N terminus and 30
residues from the C terminus of both chains.
Chain B from the apo CD23 room temperature model was used to
solve the apo cryocooled structure, yielding a molecular replace-
ment solution with a correlation coefficient of 56.7%. The Rfree test
set was generated with reflections from thin-resolution shells. The
model was rebuilt with O and refined with CNS with all data from
30 to 1.5 A˚ with jFj > 0 and with an anisotropic bulk solvent correc-
tion. Anisotropic B factor refinement, bond length and angle refine-
ment with Refmac5 (CCP4, 1994) provided a final model with 366
water molecules, an Rwork of 12.9%, and an Rfree of 17.0%. The final
model includes all residues from F158 to P291.
Chain B from the apo cryocooled structure was used to solve the
Ca2+-containing structure. A single solution with a correlation coef-
ficient of 57.9% was found by using CNS. An Rfree set was generated
with reflections from thin-resolution shells. After initial minimization
and B factor refinement, a simulated-annealing composite omit map
showed a 14s peak at the Ca2+ binding site along with reordering of
the residue side chains ligated to the calcium ion. The structure was
rebuilt with O and refined with CNS. Anisotropic B factors were re-
fined with Refmac5 (CCP4, 1994) in the final stages. The final model
includes residues 160–288 of CD23, 1 calcium ion, and 173 water
molecules. The model is missing 13 N-terminal residues, 33 C-termi-
nal residues (289–321), and internal residues 253–257. Some weak
electron density for residues 253–257 was observed but could not
be modeled. The final model has an Rwork of 16.9% and an Rfree of
20.2%.
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